Omeprazole, a potent proton pump inhibitor (PPI), reigns supreme in the treatment of acid-related disorders like heartburn, GERD, and ulcers. Its global market size is projected to reach a staggering USD 17.2 billion by 2027, presenting an ocean of opportunity for manufacturers and exporters. But navigating this vast landscape can be daunting. Fear not! This guide equips you with the knowledge and tools to identify top omeprazole buyers across the globe, capitalize on market trends, and implement winning sales strategies. Top Omeprazole Buyers by Region: North America: Abbott Laboratories, Pfizer, Teva Pharmaceuticals, Aurobindo Pharma Europe: AstraZeneca, Sanofi, Novartis, Teva Pharmaceuticals Asia Pacific: Sun Pharmaceutical Industries, Cipla, Zydus Cadila, Torrent Pharmaceuticals…